Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. M.A. Heuvelmans

Publicaties

Action plan for an international imaging framework for implementation of global low-dose CT screening for lung cancer

Corrigendum to: Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: Impact on negative-misclassifications and clinical referral rate (European Journal of Cancer (2025) 216, 115214 (S0959804924018215), (10.1016/j.ejca.2024.115214))

CT-assessed sarcopenia and immune-related adverse events in patients with lung cancer: A competing risk time-to-event analysis

Histological proven AI performance in the UKLS CT lung cancer screening study: potential for workload reduction

Artificial intelligence: the key to significant reduction in baseline LDCT lung cancer screening associated workload when used as a first-read filter

Ct-defined emphysema prevalence in a Chinese and Dutch general population

Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer

D-dimer cut-off value for pulmonary embolism diagnosis in COVID-19

Explainable machine learning model based on clinical factors for predicting the disappearance of indeterminate pulmonary nodules

Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: impact on negative-misclassifications and clinical referral rate